So. Jun 16th, 2024

Kenneth Research published a report titled “Breast Lesion Localization Market: Global Demand Analysis & Opportunity Outlook 2031” which provides a detailed overview of the global breast lesion localization market in terms of market segmentation by type, biopsy techniques, end users and by region.
Furthermore, for the in-depth analysis, the report encompasses the industry growth indicators, restraints, supply and demand risks and a detailed discussion of the current and future market trends associated with the growth of the market.
Access Full Description of Report:
Global Breast Lesion Localization Market generated the approximate revenue of US$520 million in 2021 and is expected to grow at a CAGR of ~10% over the forecast period i.e. 2022 – 2031. On the basis of Type, the market is in Wire localization, radioisotope localization, radioactive seed localization, radiooccult lesion localization, magnetic tracers and others. Of these segments, the wire localization segment is expected to grow at a moderate CAGR over the forecast period due to high accuracy in tissue localization, increasing acceptance of the surgical method among surgeons and successful outcome of the operation.
Breast lesion location is a technique used to locate abnormalities such as a lump or tumor in the breasts. The problem of breast lumps is not limited to a specific age. The market is primarily driven by the rising incidence of breast cancer, the increasing number of breast cancer screening programs and improving reimbursement. Politics. Furthermore, the increasing investment in research and development of breast cancer treatment devices, improvement of healthcare facilities and growing awareness of breast cancer early detection are few important factors contributing to the growth of the market.
Based on region, the global breast lesion localization market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America and the Middle East & Africa. Although the North America market held the largest market share in 2021, the Asia-Pacific market is expected to witness tremendous growth with a significant CAGR during the forecast period. The market is expected to see growth in this region due to rising breast cancer cases, improvement in the healthcare sector, increasing awareness of early detection among patients, and growing need for breast-conserving surgeries.
The research is global in nature and includes detailed analyzes of the market in North America (USA, Canada), Europe (UK, Germany, France, Italy, Spain, Hungary, Belgium, Netherlands and Luxembourg, NORDIC [Finland, Sweden, Norway, Denmark], Poland, Turkey, Russia, Rest of Europe), Latin America (Brazil, Mexico, Argentina, Rest of Latin America), Asia-Pacific (China, India, Japan, South Korea, Indonesia, Singapore, Malaysia, Australia, New Zealand, Rest of Asia- Pacific), Middle East and Africa (Israel, GCC [Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman], North Africa, South Africa, Rest of Middle East and Africa). Additionally, market size analysis, YOY growth and opportunity analysis, competitive studies of market players, investment opportunities,
Rising Breast Cancer Incidences Drive Growth of Breast Lesion Localization Market
Breast cancer incidences have doubled in the past decade. According to the World Health Organization (WHO), 2.3 million women were diagnosed with breast cancer and reported 685,000 deaths worldwide in 2020. Breast cancer is one of the most common types of cancer affecting women alongside skin cancer. The continuously increasing number of patients affected by breast cancer is attributed to The main factors driving the growth of the global breast lesion localization market.
However, the high cost of products and treatments along with the shortage of skilled professionals are expected to act as the main brakes on the growth of the global breast lesion localization market during the forecast period.
This report also includes the existing competitive scenario of some of the major players of the global Breast Lesion Localization Market which include company profiling MOLLI Surgical Inc., ARGON MEDICAL., Merit Medical Systems, CP Medical, STERYLAB Srl, Cook Group Incorporated, Becton, Dickinson and Company (BD), Hologic, Inc., Zimmer Biomet and PerkinElmer Inc. Profiling includes key company information, which includes business overview, products and services, key financial data and breaking news and developments. Overall, the report provides a detailed overview of the global Breast Lesion Localization Market, the industry consultants, device manufacturers, existing players looking for expansion opportunities, new players,
Request a Sample Report:
Kenneth Research is a leading provider of strategic market research and consulting services. Our goal is to provide unbiased, unparalleled market insight and industry knowledge. Analysis to help industries, conglomerates and executives make smart decisions for their future marketing strategy, expansion and investments etc. We believe that any business can expand to its new horizon provided the right guidance is available at the right time through strategic minds. Our out-of-box thinking helps our clients make smart decisions to avoid future uncertainties.
Contact for more information:
AJ Daniel
Email address: Telephone: +1 313 462 0609

Pressemitteilung teilen:

Schreibe einen Kommentar